SamaCare Releases Benchmarks for Medical Benefit Prior Authorization Performance
SamaCare announced in a press release the launch of its Medical Benefit Prior Authorization Benchmarks, a dataset that offers visibility into approval rates and time to therapy for specialty medications. The dataset is based on real prior authorization activity from tens of thousands of specialty practices using SamaCare's platform.
The benchmarks provide quarterly insights into two key metrics that affect patient access to therapy: Net Approval Rate and Mean Time to Resolution. These measures track how payer policies are applied in practice and how quickly patients move from authorization to treatment.
In addition to the public benchmarks, SamaCare is offering life sciences organizations the option to generate custom Access Snapshots for individual therapies. These reports provide deeper insights into approval performance, time to therapy, and the main factors influencing access barriers.
The release arrives amid growing attention to prior authorization reform and transparency in healthcare administration.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
AI data annotation firm Sama, which worked for Meta and OpenAI, is winding down and liquidating
ACL Digital Launches AgentixCare for Healthcare Operations
Penguin Ai survey: 62% of patients facing prior authorization delays gave up on care
Prosper AI Estimates $108 Billion Revenue Opportunity for Specialty Practices
MEDITECH and Lifemed AI Partner on Claims Automation
Daily AI Brief: the AI news that matters, in your inbox.